All these results showed that the amount of CACNA1G-AS1 and FTH1 pulled down by the AGO2 antibody significantly increased in ovarian cancer cells transfected with IGF2BP1 (Figs. 2A and 2B). This evidence concerns the gene IGF2BP1 and ovarian carcinoma.